| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2025 | Oct 10, 2025 | Adicet Bio, Inc. | 10% Owner | Buy | 100.0 | +5,000,000 | 58.71% | ✗ | $5M |
| Oct 15, 2024 | Oct 17, 2024 | Upstream Bio, Inc. | Director | Buy | 100.0 | +825,000 | 16.95% | ✗ | $14M |
| Jan 25, 2024 | Jan 26, 2024 | Adicet Bio, Inc. | Director | Buy | 100.0 | +3,125,000 | 47.01% | ✗ | $7.5M |
| Aug 15, 2023 | Aug 17, 2023 | Galecto, Inc. | 10% Owner | Sell | 20.0 | -822,680 | -26.87% | ✗ | $617K |
| Jul 31, 2023 | Aug 2, 2023 | Galecto, Inc. | 10% Owner | Sell | 20.0 | -209,400 | -6.29% | ✗ | $628.2K |
| Jul 25, 2023 | Jul 27, 2023 | Galecto, Inc. | 10% Owner | Sell | 22.5 | -39,200 | -1.16% | ✗ | $114.5K |
| Jul 13, 2023 | Jul 17, 2023 | Galecto, Inc. | 10% Owner | Sell | 20.0 | -194,700 | -5.46% | ✗ | $467.3K |
| Jun 27, 2023 | Jun 29, 2023 | Adicet Bio, Inc. | Director | Buy | 100.0 | +875,000 | 12.10% | ✗ | $1.8M |
| Apr 13, 2023 | Apr 17, 2023 | Galecto, Inc. | 10% Owner | Sell | 32.5 | -68,481 | -0.63% | ✗ | $128.3K |
| Apr 10, 2023 | Apr 12, 2023 | Galecto, Inc. | 10% Owner | Sell | 32.5 | -67,537 | -0.61% | ✗ | $121.4K |
| Apr 5, 2023 | Apr 7, 2023 | Galecto, Inc. | 10% Owner | Sell | 22.5 | -102,630 | -1.37% | ✗ | $222K |
| Jan 25, 2022 | Jan 27, 2022 | 89bio, Inc. | 10% Owner | Sell | 30.0 | -70,573 | -0.95% | ✗ | $592.4K |
| Nov 2, 2020 | Nov 4, 2020 | Galecto, Inc. | Director | Buy | 100.0 | +733,333 | 25.48% | ✗ | $11M |
| Sep 21, 2020 | Sep 23, 2020 | 89bio, Inc. | Director | Sell | 16.3 | -275,000 | -6.87% | ✗ | $7.7M |
| Nov 11, 2019 | Nov 13, 2019 | 89bio, Inc. | Director | Buy | 100.0 | +837,500 | 137.02% | ✗ | $13.4M |